Lindbrook Capital, LLC Dr Reddys Laboratories LTD Transaction History

Lindbrook Capital, LLC

$1.18 Billion
Q3 2024

A detailed history of Lindbrook Capital, LLC transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Lindbrook Capital, LLC holds 3,862 shares of RDY stock, worth $55,921. This represents 0.03% of its overall portfolio holdings.

Number of Shares

3,862

Previous 4,109 6.01%

Holding current value

$55,921

Previous $313,000 2.24%

% of portfolio

0.03%

Previous 0.03%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$75.41 - $84.21 $18,626 - $20,799	-247 Reduced 6.01%	3,862 $306,000
Q2 2024 Jul 31, 2024	BUY	$68.26 - $76.19 $16,109 - $17,980	236 Added 6.09%	4,109 $313,000
Q1 2024 Apr 25, 2024	BUY	$67.36 - $77.59 $23,845 - $27,466	354 Added 10.06%	3,873 $284,000
Q4 2023 Jan 31, 2024	BUY	$64.27 - $69.9 $36,312 - $39,493	565 Added 19.13%	3,519 $244,000
Q3 2023 Oct 25, 2023	BUY	$61.9 - $72.77 $5,447 - $6,403	88 Added 3.07%	2,954 $197,000
Q2 2023 Jul 28, 2023	SELL	$53.34 - $63.11 $9,334 - $11,044	-175 Reduced 5.75%	2,866 $180,000
Q1 2023 Apr 26, 2023	BUY	$51.63 - $56.93 $12,907 - $14,232	250 Added 8.96%	3,041 $173,000
Q4 2022 Jan 24, 2023	BUY	$51.15 - $57.45 $24,705 - $27,748	483 Added 20.93%	2,791 $0
Q3 2022 Nov 10, 2022	SELL	$49.9 - $57.32 $1,596 - $1,834	-32 Reduced 1.37%	2,308 $121,000
Q2 2022 Aug 01, 2022	BUY	$49.62 - $58.13 $17,069 - $19,996	344 Added 17.23%	2,340 $130,000
Q1 2022 Apr 21, 2022	BUY	$48.27 - $65.25 $23,652 - $31,972	490 Added 32.54%	1,996 $111,000
Q4 2021 Jan 18, 2022	BUY	$59.5 - $67.25 $10,472 - $11,836	176 Added 13.23%	1,506 $99,000
Q3 2021 Nov 05, 2021	SELL	$60.19 - $75.29 $2,648 - $3,312	-44 Reduced 3.2%	1,330 $87,000
Q2 2021 Jul 27, 2021	BUY	$62.12 - $74.2 $1,925 - $2,300	31 Added 2.31%	1,374 $101,000
Q1 2021 Apr 28, 2021	BUY	$57.98 - $73.08 $3,304 - $4,165	57 Added 4.43%	1,343 $82,000
Q4 2020 Jan 27, 2021	BUY	$62.61 - $71.29 $751 - $855	12 Added 0.94%	1,286 $92,000
Q3 2020 Nov 03, 2020	SELL	$51.39 - $72.41 $18,654 - $26,284	-363 Reduced 22.17%	1,274 $89,000
Q2 2020 Jul 27, 2020	BUY	$39.55 - $54.65 $2,214 - $3,060	56 Added 3.54%	1,637 $87,000
Q1 2020 Apr 22, 2020	SELL	$34.75 - $45.85 $903 - $1,192	-26 Reduced 1.62%	1,581 $64,000
Q4 2019 Jan 27, 2020	BUY	$36.66 - $41.78 $1,869 - $2,130	51 Added 3.28%	1,607 $65,000
Q3 2019 Oct 31, 2019	BUY	$34.82 - $39.26 $3,795 - $4,279	109 Added 7.53%	1,556 $59,000
Q2 2019 Jul 24, 2019	BUY	$36.05 - $42.76 $2,559 - $3,035	71 Added 5.16%	1,447 $54,000
Q1 2019 Apr 23, 2019	BUY	$35.77 - $40.57 $3,004 - $3,407	84 Added 6.5%	1,376 $55,000
Q4 2018 Feb 07, 2019	BUY	$31.89 - $38.44 $41,201 - $49,664	1,292 New	1,292 $48,000

Others Institutions Holding RDY

# of Institutions

245

Shares Held

23.1M

Call Options Held

12.7K

Put Options Held

6.1K

View Full List

About DR REDDYS LABORATORIES LTD

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.4B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

More about RDY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.

Account

Lindbrook Capital, LLC Dr Reddys Laboratories LTD Transaction History